Biotech business development & non‑dilutive funding

Twenty-five years inside biotech deals —
now working for your next milestone.

Dr. Jahan Ali helps biotech founders move their companies forward, drawing on a career spent building biotech companies from the inside: negotiating partnerships, investing in early-stage ventures, and designing the programs that get founders to their next inflection point.

Dr. Jahan Ali
Where founders bring me in
Discovery Market research &
business plans
IND-enabling SBIR/STTR, EDA, NYS
& foundation grants
Early clinical In/out-licensing &
collaboration deals
Growth Fractional executive
leadership
Scale Board & investor
advisory
Dr. Jahan Ali, headshot
Ph.D.NYU School
of Medicine
PostdocRockefeller
University
About

A rare, on-the-ground view of what early-stage companies actually need.

Dr. Jahan Ali works with biotech founders to move their companies forward — drawing on 25 years spent building biotech companies from the inside, negotiating partnerships, investing in early-stage ventures, and designing the programs that help founders reach their next milestone.

She has negotiated a wide range of agreements, including in- and out-licensing, research collaborations, manufacturing agreements, and stock purchase agreements — experience built across roles as Director of Business Development at the International AIDS Vaccine Initiative, a licensing professional at the Hospital for Special Surgery and Mount Sinai, and life science investment lead at the Partnership Fund, a private fund founded by Henry Kravis.

At the Bioventure eLab at Weill Cornell, she built an investor conference, mentorship program, and startup competitions for founders. At SymBiosis Capital, she secured a multi-million-dollar commitment from investors to grow the regional life science ecosystem.

In her consulting work, she helps companies secure non-dilutive funding — including SBIR/STTR, U.S. EDA, New York State, and foundation grants — and build the market research and business plans behind it.

Career

Built across the deal table and the lab bench

Director of Business Development

International AIDS Vaccine Initiative (IAVI)

Led partnership and licensing strategy across a global vaccine R&D portfolio.

Licensing Professional

Hospital for Special Surgery & Mount Sinai

Managed in- and out-licensing of institutional technology and research agreements.

Life Science Investment Lead

The Partnership Fund (founded by Henry Kravis)

Sourced and evaluated early-stage life science investments for a private fund.

Program Builder

Bioventure eLab, Weill Cornell

Built an investor conference, mentorship program, and startup competitions for founders.

Ecosystem Lead

SymBiosis Capital

Secured a multi-million-dollar commitment from investors to grow the regional life science ecosystem.

Right now

Current roles

Fractional CEO

GynStrong

Fractional executive leadership
Fractional COO

NomoCan

Fractional executive leadership
Board advisor

VoiceLove

Strategic & governance advisory
Executive in residence

Digitalis Commons

Founder & venture support
Services

Four places I plug in

Each is a clause in the same deal: getting your company to its next milestone without giving up more than it has to.

01 / Funding

Non-dilutive funding

Strategy and hands-on support to secure grant funding without giving up equity.

  • SBIR / STTR
  • U.S. Economic Development Administration (EDA)
  • New York State programs
  • Foundation grants
02 / Diligence

Market research & business plans

The research and narrative that grant reviewers, partners, and investors need to say yes.

  • Competitive & market landscape analysis
  • Business plans built around your funding strategy
03 / Deals

Partnership & licensing negotiation

Deal experience across the full range of agreements an early-stage biotech will face.

  • In- and out-licensing
  • Research collaboration agreements
  • Manufacturing agreements
  • Stock purchase agreements
04 / Leadership

Fractional executive leadership

Operating leadership for companies that need executive bandwidth without a full-time hire.

  • Fractional CEO / COO engagements
  • Board & advisory roles
Podcast

Conversations on the road to a deal

Short, candid conversations with founders, investors, and operators about what it actually takes to move a biotech company forward.

EPISODE 12 · 34 MIN

Negotiating your first licensing deal

What changes once a term sheet is on the table, and where first-time founders give away the most.

EPISODE 11 · 41 MIN

Grants over equity: building a non-dilutive runway

A practical walkthrough of how SBIR/STTR and state grant strategy actually fits into a fundraising plan.

EPISODE 10 · 29 MIN

What a fractional exec sees in the first 90 days

The patterns that show up across every early-stage company, and the ones that are unique to yours.

Note for Dr. Ali: add your podcast's real name, episode players (e.g. embedded Spotify/Apple players), and subscribe links here.
Get in touch

Let's talk about your next milestone.

Whether it's a grant strategy, a partnership in motion, or fractional leadership — happy to start with a short call.

Currently
  • GynStrongFractional CEO
  • NomoCanFractional COO
  • VoiceLoveBoard Advisor
  • Digitalis CommonsExecutive in Residence